85 related articles for article (PubMed ID: 7565300)
1. Nalmefene--a long-acting injectable opioid antagonist.
Med Lett Drugs Ther; 1995 Oct; 37(960):97-8. PubMed ID: 7565300
[No Abstract] [Full Text] [Related]
2. Duration of opioid antagonism by nalmefene and naloxone in the dog. A nonparametric pharmacodynamic comparison based on generalized cross-validated spline estimation.
Wilhelm JA; Veng-Pedersen P; Zakszewski TB; Osifchin E; Waters SJ
Int J Clin Pharmacol Ther; 1995 Oct; 33(10):540-5. PubMed ID: 8574503
[TBL] [Abstract][Full Text] [Related]
3. Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone.
Dunbar JL; Turncliff RZ; Dong Q; Silverman BL; Ehrich EW; Lasseter KC
Alcohol Clin Exp Res; 2006 Mar; 30(3):480-90. PubMed ID: 16499489
[TBL] [Abstract][Full Text] [Related]
4. Effects of liver disease on the disposition of the opioid antagonist nalmefene.
Frye RF; Matzke GR; Schade R; Dixon R; Rabinovitz M
Clin Pharmacol Ther; 1997 Jan; 61(1):15-23. PubMed ID: 9024170
[TBL] [Abstract][Full Text] [Related]
5. The opioid receptor antagonist nalmefene reduces responding maintained by ethanol presentation: preclinical studies in ethanol-preferring and outbred Wistar rats.
June HL; Grey C; Warren-Reese C; Durr LF; Ricks-Cord A; Johnson A; McCane S; Williams LS; Mason D; Cummings R; Lawrence A
Alcohol Clin Exp Res; 1998 Dec; 22(9):2174-85. PubMed ID: 9884166
[TBL] [Abstract][Full Text] [Related]
6. Nalmefene. JF 1, nalmetrene, NIH 10365, ORF 11676, Arthrene, Cervene, Incystene, Revex.
Drugs R D; 1999 Jan; 1(1):32-3. PubMed ID: 10565979
[No Abstract] [Full Text] [Related]
7. Vivitrex (Alkermes/Cephalon).
Heading CE
Curr Opin Investig Drugs; 2006 Jan; 7(1):81-8. PubMed ID: 16425675
[TBL] [Abstract][Full Text] [Related]
8. Nalmefene hydrochloride.
Chumpa A
Pediatr Emerg Care; 1999 Apr; 15(2):141-3. PubMed ID: 10220088
[No Abstract] [Full Text] [Related]
9. Opioid antagonists.
Barnett V; Twycross R; Mihalyo M; Wilcock A
J Pain Symptom Manage; 2014 Feb; 47(2):341-52. PubMed ID: 24512968
[No Abstract] [Full Text] [Related]
10. Nalmefene: a long-acting opioid antagonist. Clinical applications in emergency medicine.
Wang DS; Sternbach G; Varon J
J Emerg Med; 1998; 16(3):471-5. PubMed ID: 9610980
[TBL] [Abstract][Full Text] [Related]
11. Nalmefene for elective reversal of procedural sedation in children.
Chumpa A; Kaplan RL; Burns MM; Shannon MW
Am J Emerg Med; 2001 Nov; 19(7):545-8. PubMed ID: 11698998
[TBL] [Abstract][Full Text] [Related]
12. Behavioral effects of 6-methylene naltrexone (nalmefene) in rhesus monkeys.
France CP; Gerak LR
J Pharmacol Exp Ther; 1994 Sep; 270(3):992-9. PubMed ID: 7932212
[TBL] [Abstract][Full Text] [Related]
13. Open-label trial of oral nalmefene therapy for the pruritus of cholestasis.
Bergasa NV; Schmitt JM; Talbot TL; Alling DW; Swain MG; Turner ML; Jenkins JB; Jones EA
Hepatology; 1998 Mar; 27(3):679-84. PubMed ID: 9500694
[TBL] [Abstract][Full Text] [Related]
14. [Prevention of undesirable effects during the use of opiate antagonists].
Rust M
Klin Anasthesiol Intensivther; 1993; 42():108-16. PubMed ID: 8450619
[No Abstract] [Full Text] [Related]
15. Longer occupancy of opioid receptors by nalmefene compared to naloxone as measured in vivo by a dual-detector system.
Kim S; Wagner HN; Villemagne VL; Kao PF; Dannals RF; Ravert HT; Joh T; Dixon RB; Civelek AC
J Nucl Med; 1997 Nov; 38(11):1726-31. PubMed ID: 9374341
[TBL] [Abstract][Full Text] [Related]
16. Use of a narcotic antagonist (nalmefene) to suppress self-mutilative behavior in a stallion.
Dodman NH; Shuster L; Court MH; Patel J
J Am Vet Med Assoc; 1988 Jun; 192(11):1585-6. PubMed ID: 3410777
[TBL] [Abstract][Full Text] [Related]
17. In vivo characterization of 6beta-naltrexol, an opioid ligand with less inverse agonist activity compared with naltrexone and naloxone in opioid-dependent mice.
Raehal KM; Lowery JJ; Bhamidipati CM; Paolino RM; Blair JR; Wang D; Sadée W; Bilsky EJ
J Pharmacol Exp Ther; 2005 Jun; 313(3):1150-62. PubMed ID: 15716384
[TBL] [Abstract][Full Text] [Related]
18. Naltrexone (vivitrol)--a once-monthly injection for alcoholism.
Med Lett Drugs Ther; 2006 Jul; 48(1240):63-4. PubMed ID: 16874283
[No Abstract] [Full Text] [Related]
19. [Pharmacokinetics of nalmefene after a single or multiple intravenous doses in Chinese healthy volunteers].
Liao RF; Zeng ZP; Wen YG
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1816-9. PubMed ID: 18971181
[TBL] [Abstract][Full Text] [Related]
20. 6beta-naltrexol preferentially antagonizes opioid effects on gastrointestinal transit compared to antinociception in mice.
Yancey-Wrona JE; Raymond TJ; Mercer HK; Sadée W; Bilsky EJ
Life Sci; 2009 Sep; 85(11-12):413-20. PubMed ID: 19583969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
